Jeff Cole

Jeff Cole brings over 25 years of experience in global pharmaceutical manufacturing and commercial operations, finance, and corporate development. He has served as a consultant to the Company since November 2023. Since August 2010, Mr. Cole has served as Principal of J. Scott Capital, LLC, a firm that provides executive and capital resources to emerging […]

Douglas W. Losordo

Losordo joins Cadrenal from American Regent, Inc., where he served as Global Head Clinical Research, Development and Operations. American Regent, a Daiichi Sankyo Group Company, develops, manufactures, and supplies high quality sterile injectables for healthcare providers, clinics and hospitals across the United States and Canada. Prior to American Regent, he served as Chief Medical Officer […]

Matthew Szot

Matthew Szot has served as our Chief Financial Officer since May 2022. From March 2010 to November 2021, Mr. Szot served as Executive Vice President and Chief Financial Officer of S&W Seed Company, a Nasdaq-listed agricultural seed biotechnology company. Since September 2020, Mr. Szot has served on the Board of Directors and as Chairman of […]

Quang Pham

Quang Pham has served as our Chief Executive Officer since he formed the Company. He previously served as Chairman & CEO of Espero BioPharma, Inc., a company he also founded and the previous sponsor of the tecarfarin IND. He then served as a consultant to HESP LLC, the assignee for Espero to Horizon Technology Finance. […]

Skip to content